| Swiss Medical Weekly | |
| Formernames: | Correspondenz-Blatt für Schweizer Aerzte, Schweizerische Medizinische Wochenschrift |
| Editor: | Adriano Aguzzi and Gérard Waeber |
| Discipline: | Medicine |
| Abbreviation: | Swiss Med. Wkly. |
| Publisher: | SMW supporting association |
| Frequency: | continuous online |
| History: | 1871-present |
| Impact: | 4.203 |
| Impact-Year: | 2021 |
| Website: | https://smw.ch/ |
| Link2: | https://smw.ch/index.php/smw/issue/archive |
| Link2-Name: | Online archive |
| Oclc: | 807721576 |
| Issn: | 1424-3997 |
The Swiss Medical Weekly is a peer-reviewed open access medical journal published by the SMW supporting association. It was established in 1871 as the Correspondenz-Blatt für Schweizer Aerzte, then renamed to Schweizerische Medizinische Wochenschrift, before obtaining its current title in 2001. SMW was one of the first journals to adhere to the principles of Diamond open access (also known as Platinum Open Access). The editors-in-chief are Adriano Aguzzi and Gérard Waeber.
The journal is abstracted and indexed in:
According to the Journal Citation Reports, the journal has a 2021 impact factor of 4.203.[1]
In 1957 Roland Kuhn published an observational study on the effectiveness of Imipramine in treating Depression (mood). [2] Other examples are the fundoplication described by Rudolf Nissen[3] in 1956 and the first description of a haemolytic-uraemic syndrome by Conrad Gasser in 1955.[4]